Simplex Trading, LLC Corcept Therapeutics Inc Transaction History

Simplex Trading, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	BUY	$19.2 - $24.47 $2,649 - $3,376	138 New	138 $2,000
Q2 2022 Aug 03, 2022	BUY	$17.33 - $25.3 $2,859 - $4,174	165 New	165 $3,000
Q2 2019 Jul 26, 2019	SELL	$9.78 - $12.76 $130,269 - $169,963	-13,320 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$10.03 - $15.71 $133,599 - $209,257	13,320 New	13,320 $0
Q4 2018 Jan 16, 2019	SELL	$11.29 - $17.19 $13,875 - $21,126	-1,229 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$12.27 - $15.65 $15,079 - $19,233	1,229 New	1,229 $17,000

403

84.3M

1.04M

1.33M

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.81B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.